What the CEA test shows
Carcinoembryonic antigen (CEA) is a glycoprotein your body makes during fetal development, to help build the lining of the gut, pancreas and liver. Production nearly stops before birth, so healthy adults carry only trace levels. When certain tumors — or some non-cancer conditions — switch that gene back on, CEA rises, which is what the blood test measures. StatPearls describes it as one of the most widely used tumor markers in medicine.
CEA is best known as a colorectal cancer marker — it is raised in the blood in most colorectal cancers, roughly 70% by the time they are found and more often once the disease is advanced — but it is not specific to one organ, and also rises with cancers of the pancreas, stomach, lung, breast, ovary (mucinous type) and medullary thyroid. That broad behavior sets it apart from its panel-mates: PSA points to the prostate, CA 19-9 to the pancreas and bile ducts, CA 15-3 to the breast, CA 125 to the ovary, and AFP to the liver and germ-cell tumors.
Crucially, CEA is a monitoring tool, not a screening test: it is used to judge prognosis when a bowel cancer is diagnosed, to watch for recurrence after treatment, and to track whether advanced disease responds to therapy — never to look for cancer in a healthy person, as the NCI explains.
CEA normal range
CEA is reported in ng/mL, which equals the SI unit µg/L (1 ng/mL = 1 µg/L), so US and European reports read the same. The value that matters most here is not sex or age but smoking status, because tobacco raises CEA on its own:
| Group | Orientation, ng/mL (= µg/L) |
|---|---|
| Adults, non-smokers | up to ~2.5–3.0 |
| Adults, smokers | up to ~5.0 |
| Pregnancy / recent illness | can be mildly raised |
Sex and age barely shift the number. MedlinePlus gives 0–2.5 ng/mL for non-smokers and up to 5 ng/mL for smokers; the Cleveland Clinic uses a similar 0–3 ng/mL. Reference ranges depend on the lab, the assay and whether you smoke — read your result against your own report, and compare serial results only from the same laboratory.
Why CEA is high
For a tumor marker, high is the direction that matters. Causes run from common and harmless to serious, roughly by frequency:
- Smoking — the commonest benign reason for a mildly raised CEA; levels usually settle within months of quitting.
- Liver and biliary disease — cirrhosis, hepatitis and bile-duct obstruction all push CEA up, because the liver is where CEA is normally cleared.
- Inflammatory gut conditions — inflammatory bowel disease (Crohn’s, ulcerative colitis), diverticulitis, peptic ulcer and pancreatitis.
- Other benign causes — chronic lung disease (COPD), chronic kidney disease, hypothyroidism and some benign breast conditions.
- Cancer — colorectal cancer classically, plus other adenocarcinomas (pancreas, stomach, lung, breast, ovary, thyroid). Higher numbers mean more: a level above roughly 10 ng/mL raises concern, and values above about 20 ng/mL suggest a large tumor burden or spread.
Benign causes rarely push CEA far above the cutoff, so a modest rise is usually not cancer. When is it urgent? The key scenario is a rising CEA during follow-up after colorectal cancer treatment — a confirmed, sustained climb can signal recurrence months before symptoms and warrants prompt imaging, as set out in the ASCO surveillance guideline. A markedly high value in someone not previously diagnosed also needs timely work-up.
Why CEA is low
A low or undetectable CEA is the normal, reassuring state — there is no disease of “too little” CEA. Its meaning depends on the context:
- In a healthy person: a low result is exactly what is expected and needs no action.
- After cancer treatment: a CEA that was high before surgery and then falls to normal suggests the tumor was fully removed; a stable low value on follow-up is reassuring.
- The important caveat: a normal CEA does not rule out cancer. Many colorectal cancers — especially early-stage ones — make little or no CEA, which is exactly why the marker is useless for screening. A normal number should never override worrying symptoms or a positive colonoscopy.
What to test alongside
CEA is rarely read alone. Depending on the clinical question, it is paired with other tumor markers and organ checks:
- CA 19-9 — co-ordered in colorectal cancer and the main marker for pancreatic and bile-duct cancer.
- CA 15-3 — used with CEA to follow breast cancer.
- CA 125 and HE4 — ovarian markers that help when the primary site is unclear.
- AFP — liver and germ-cell tumors.
- PSA — the prostate marker, the other test men often ask about.
- ALT and AST — liver enzymes, because the liver both clears CEA and is the commonest site of colorectal spread.
The definitive tests for bowel cancer, though, are structural — colonoscopy and imaging — not a blood marker.
What to do about an abnormal result
- Don’t panic over a single number. One mildly raised CEA is not a cancer diagnosis; smoking and benign gut, liver or lung conditions are far more common.
- Don’t self-order CEA to screen yourself. It is not a screening test: a normal result can falsely reassure, and a raised one triggers needless alarm and scans.
- Repeat and trend. The direction of change over time matters more than any single value, and results only compare when run on the same assay in the same lab.
- If you are on colorectal-cancer follow-up, a confirmed, sustained rise prompts your team to arrange imaging (a CT scan) and colonoscopy, often before you feel anything.
- See your primary-care doctor first. They interpret the result in context and refer you to gastroenterology or oncology when warranted, rather than jumping to treatment.
Mini-FAQ
What does a high CEA level mean?
A high CEA can reflect cancer — most often colorectal, but also pancreatic, lung, breast, stomach or thyroid cancer. It is also raised by non-cancer causes such as smoking, liver disease and inflammatory bowel disease, so one high value is never a diagnosis on its own.
Can CEA be used to screen for cancer?
No. The NCI and ASCO do not recommend CEA for screening because it misses many early cancers and is raised by many harmless conditions. Colonoscopy and stool tests, not CEA, are the tools used to screen for colorectal cancer.
Does smoking raise CEA?
Yes. Smokers run higher baseline levels, so many labs use a cutoff around 5 ng/mL for smokers versus roughly 2.5–3 ng/mL for non-smokers. Levels usually fall back within a few months of quitting.
Can CEA be normal if I have cancer?
Yes. Many colorectal cancers — especially early-stage or poorly differentiated ones — make little CEA, so a normal result cannot rule out cancer. This is one reason CEA is not used for screening or diagnosis.
What CEA level is considered high?
Anything above your lab’s cutoff — about 3 ng/mL in non-smokers and 5 ng/mL in smokers — is flagged, but mild elevations are often benign. Levels above roughly 10 ng/mL raise more concern, and very high values, often above 20 ng/mL, point toward advanced or metastatic disease.
How is CEA used after colorectal cancer treatment?
After curative surgery, guidelines suggest checking CEA every 3–6 months for about 5 years to catch recurrence early. A confirmed, sustained rise prompts imaging such as a CT scan and colonoscopy, often before symptoms appear.
